Shanghai Kehua Bio-engineering Unveils Polaris V150 at MEDICA 2025

Shanghai Kehua Bio-engineering Co., Ltd. (KHB), a leader in in-vitro diagnostic solutions, introduced its latest innovation, the Polaris V150 Automatic Chemiluminescence Immunoassay Analyzer, at the renowned MEDICA 2025 event. The compact device, designed specifically for small and medium-sized laboratories, aims to enhance operational efficiency with its state-of-the-art features.

The Polaris V150, with a space-saving footprint of 0.36 m², can conduct 150 tests per hour. Its integration of an ALP–AMPPD chemiluminescence system ensures precision across assays, powered by an intuitive interface for ease of operation.

The device supports over 60 assays and incorporates intelligent systems like real-time monitoring and automatic maintenance, promising laboratory continuity. Its presence at MEDICA 2025 highlights global interest in compact, efficient immunoassay solutions.